Total Valuation
OWC Pharmaceutical Research has a market cap or net worth of $497.00. The enterprise value is -$3.46M.
Market Cap$497.00
Enterprise Value-$3.46M
Share Statistics
OWC Pharmaceutical Research has 497,498,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding497,498,350
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OWC Pharmaceutical Research’s return on equity (ROE) is 1.09 and return on invested capital (ROIC) is -137.91%.
Return on Equity (ROE)1.09
Return on Assets (ROA)-2.89
Return on Invested Capital (ROIC)-137.91%
Return on Capital Employed (ROCE)-1.38
Revenue Per Employee0.00
Profits Per Employee-1.14M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OWC Pharmaceutical Research is ―. OWC Pharmaceutical Research’s PEG ratio is -1.24.
PE Ratio―
PS Ratio0.00
PB Ratio-162.34
Price to Fair Value-162.34
Price to FCF-606.45
Price to Operating Cash Flow>-0.01
PEG Ratio-1.24
Income Statement
In the last 12 months, OWC Pharmaceutical Research had revenue of 0.00 and earned -10.26M in profits. Earnings per share was -0.07.
Revenue0.00
Gross Profit―
Operating Income-4.30M
Pretax Income-10.26M
Net Income-10.26M
EBITDA-3.56M
Earnings Per Share (EPS)-0.07
Cash Flow
In the last 12 months, operating cash flow was -2.74M and capital expenditures -7.04K, giving a free cash flow of -2.75M billion.
Operating Cash Flow-2.74M
Free Cash Flow-2.75M
Free Cash Flow per Share>-0.01
Dividends & Yields
OWC Pharmaceutical Research pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-3.62
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
OWC Pharmaceutical Research upcoming earnings date is May 15, 2018, After Close (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateMay 15, 2018
Ex-Dividend Date―
Financial Position
OWC Pharmaceutical Research as a current ratio of 8.03, with Debt / Equity ratio of 0.00%
Current Ratio8.03
Quick Ratio8.03
Debt to Market Cap0.00
Net Debt to EBITDA0.97
Interest Coverage Ratio-1.43K
Taxes
In the past 12 months, OWC Pharmaceutical Research has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
OWC Pharmaceutical Research EV to EBITDA ratio is -429.02, with an EV/FCF ratio of -605.07.
EV to Sales0.00
EV to EBITDA-429.02
EV to Free Cash Flow-605.07
EV to Operating Cash Flow-611.85
Balance Sheet
OWC Pharmaceutical Research has $1.47M in cash and marketable securities with $47.00K in debt, giving a net cash position of $1.42M billion.
Cash & Marketable Securities$1.47M
Total Debt$47.00K
Net Cash$1.42M
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for OWC Pharmaceutical Research is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―